Sonic Fund II, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Fennec Pharmaceuticals Inc. Common stock, no par value (the "Shares") (FENC)

Filing Manager: Sonic Fund II, L.P.
Reporting Manager: Kam Lawrence
Security: Fennec Pharmaceuticals Inc. Common stock, no par value (the "Shares")
Symbol: FENC
Shares outstanding: 34,145,841 shares
Disclosed Ownership: 2,799,959 shares
Ownership: 8.2%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 10:39:33 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title
Sonic Fund II, L.P.	7.6%	2,607,357	0	2,607,357	/s/ Lawrence Kam	Lawrence Kam, Managing Member of Sonic GP LLC, its General Partner
Sonic GP LLC	7.6%	2,607,357	0	2,607,357	/s/ Lawrence Kam	Lawrence Kam, Managing Member
Kam Lawrence	8.2%	2,799,959	190,202	2,607,357	/s/ Lawrence Kam	Lawrence Kam, a natural person